69
|
242
|
5l5oD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
58
|
222
|
5l52L |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
59
|
195
|
5l5qJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
58
|
204
|
5l5xI |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
163
|
533
|
5kikA |
Cmla beta-hydroxylase in chemically reduced diferrous state |
71
|
233
|
5l5bM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
58
|
226
|
5l5jH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
70
|
233
|
5l5sM |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
71
|
243
|
5l5sF |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
70
|
240
|
5l55C |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
68
|
240
|
5l5qC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
62
|
211
|
5l5eK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
65
|
250
|
5l5fA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
65
|
250
|
5l5iA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
61
|
222
|
5l5iL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
59
|
226
|
5l5eH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
57
|
204
|
5l5hI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
63
|
211
|
5l5bK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
69
|
244
|
5l5qB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
62
|
231
|
5l5eE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
61
|
211
|
5l5dK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
67
|
233
|
5l5fM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
61
|
222
|
5l5bL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
67
|
250
|
5l5jA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
71
|
244
|
5l5fB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
62
|
231
|
5l5qE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
71
|
212
|
5l54K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
66
|
250
|
5l5sA |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
67
|
242
|
5l52D |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
65
|
225
|
5l52M |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
63
|
241
|
5l5hG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
59
|
196
|
5l5qN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
60
|
195
|
5l5uJ |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
69
|
240
|
5l54C |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
66
|
240
|
5l5bC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
63
|
231
|
5l5oE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
69
|
242
|
5l5hD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
61
|
195
|
5l55J |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
66
|
240
|
5l5hC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
59
|
226
|
5l5yH |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
58
|
204
|
5l5jI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
70
|
243
|
5l5jF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
63
|
241
|
5l5fG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
57
|
204
|
5l5iI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
70
|
244
|
5l5oB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
58
|
222
|
5l5tL |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
65
|
211
|
5l5uK |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
65
|
231
|
5l55E |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
58
|
196
|
5l5oN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
58
|
196
|
5l5rN |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |